PTEN and lung carcinoma: Moreover, the simultaneous modulation of miR-126-3p and miR-221-3p inhibits the phosphatase and tensin homolog (PTEN) and the phosphoinositide-3-kinase receptor 2 (PI3KR2), thus reducing metastatic dissemination of lung cancer cells [13].